How Are MDC, ANP And NUH Performing On ASX?

  • Dec 04, 2018 AEDT
  • Team Kalkine
How Are MDC, ANP And NUH Performing On ASX?

Medlab Clinical Limited (ASX: MDC)

With the market open, the stock price of MDC was A$0.390. It went as high as A$0.395. The lowest price recorded for the day was A$0.385. By the end of the trading on December 4, 2018, the share price increased by 1.316% and the last traded price of the share was A$0.385 with the stock holding a market capitalization of A$79.05 million. Also, the last traded price is close to 52 weeks low price.

The increase in the share price was due to the announcement made by the company regarding its expansion in the European market. As per the announcement, MDC Europe which is the subsidiary of the Medlab Clinical Limited will be taking care of all the current and upcoming dealings related to re NanaBis and will also be dealing based on the proposed drug registration model.  

Antisense Therapeutics Limited (ASX: ANP)

After the announcement on ASX regarding the receipt of research and development tax incentive payment, today the share traded flat on ASX. The opening price of the share was A$0.032. This level remained constant regarding the day’s high and low price while the stock reported a market capitalization of A$11.89 million. As per the announcement, the company has received an R&D tax incentive refund payment $284,000 from the Australian Taxation Office about the expenditure incurred in FY2018. In FY2019, the company further requires a higher amount for the ongoing clinical trial of ALT1102.

Trading flat on ASX means that the investors are not ready to take any action on their stocks. There is also uncertainty in the market. Also, as per the chart, the indicator MACD line is moving in the downward direction and is parallel to the signal line.

Nuheara Limited (ASX: NUH)

The share price of NUH zooms by 11.538% which is equivalent to 0.009 points. With the market open on 04 December 2018, the market price of the share is A$0.079. It went as high as A$0.087. The lowest price recorded for the day was A$0.079 with the stock holding a market capitalization of A$69.53 million.

The increase in the share price was due to the recent update made by the company where the company was able to complete oversubscribed $5 million through the equity raising. The company also received support from the new institutional investors. Further, the company is going to use these funds to increase the inventory levels of IQbuds Boost and also used in the hearing aid supply contract and their respective marketing and related sales activities.

As per the chart, the indicator MACD line is above the signal line and is moving in the upward direction.


Disclaimer

This website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The website has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold. We are neither licensed nor qualified to provide investment advice.

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK